196 related articles for article (PubMed ID: 23605251)
1. Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 years.
Sato R; Gomez Rey G; Nelson S; Pinsky B
Appl Health Econ Health Policy; 2013 Jun; 11(3):251-8. PubMed ID: 23605251
[TBL] [Abstract][Full Text] [Related]
2. Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis.
Rozenbaum MH; Mangen MJ; Huijts SM; van der Werf TS; Postma MJ
Vaccine; 2015 Jun; 33(28):3193-9. PubMed ID: 25981488
[TBL] [Abstract][Full Text] [Related]
3. Treatment costs of community-acquired pneumonia in an employed population.
Colice GL; Morley MA; Asche C; Birnbaum HG
Chest; 2004 Jun; 125(6):2140-5. PubMed ID: 15189934
[TBL] [Abstract][Full Text] [Related]
4. All-cause community acquired pneumonia cost by age and risk in real-world conditions of care in Spain.
Rejas J; Sicras-Mainar A; Sicras-Navarro A; Lwoff N; Méndez C
Expert Rev Pharmacoecon Outcomes Res; 2022 Jul; 22(5):853-867. PubMed ID: 34949148
[TBL] [Abstract][Full Text] [Related]
5. The 1-year economic burden of community-acquired pneumonia (CAP) initially managed in the outpatient setting in the USA.
Divino V; Schranz J; Early M; Shah H; Jiang M; DeKoven M
J Comp Eff Res; 2020 Jan; 9(2):127-140. PubMed ID: 31840552
[No Abstract] [Full Text] [Related]
6. The annual economic burden among patients hospitalized for community-acquired pneumonia (CAP): a retrospective US cohort study.
Divino V; Schranz J; Early M; Shah H; Jiang M; DeKoven M
Curr Med Res Opin; 2020 Jan; 36(1):151-160. PubMed ID: 31566005
[No Abstract] [Full Text] [Related]
7. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
[TBL] [Abstract][Full Text] [Related]
8. Clinical and economic burden of community-acquired pneumonia in the Veterans Health Administration, 2011: a retrospective cohort study.
McLaughlin JM; Johnson MH; Kagan SA; Baer SL
Infection; 2015 Dec; 43(6):671-80. PubMed ID: 25980561
[TBL] [Abstract][Full Text] [Related]
9. The cost of treating community-acquired pneumonia.
Niederman MS; McCombs JS; Unger AN; Kumar A; Popovian R
Clin Ther; 1998; 20(4):820-37. PubMed ID: 9737840
[TBL] [Abstract][Full Text] [Related]
10. Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study.
Vissink CE; Huijts SM; de Wit GA; Bonten MJ; Mangen MJ
BMC Infect Dis; 2016 Sep; 16(1):466. PubMed ID: 27589847
[TBL] [Abstract][Full Text] [Related]
11. CAPECO: Cost evaluation of community acquired pneumonia managed in primary care.
Personne V; Chevalier J; Buffel du Vaure C; Partouche H; Gilberg S; de Pouvourville G
Vaccine; 2016 Apr; 34(19):2275-80. PubMed ID: 26979138
[TBL] [Abstract][Full Text] [Related]
12. Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin.
Signorovitch JE; Sheng Duh M; Sengupta A; Gu A; Grant R; Raut M; Mody SH; Schein J; Fisher AC; Ng D
Curr Med Res Opin; 2010 Feb; 26(2):355-63. PubMed ID: 19995325
[TBL] [Abstract][Full Text] [Related]
13. Disease burden of hospitalized community-acquired pneumonia in South Korea: Analysis based on age and underlying medical conditions.
Choi MJ; Song JY; Noh JY; Yoon JG; Lee SN; Heo JY; Yoon JW; Jo YM; Cheong HJ; Kim WJ
Medicine (Baltimore); 2017 Nov; 96(44):e8429. PubMed ID: 29095281
[TBL] [Abstract][Full Text] [Related]
14. Community-acquired pneumonia: economics of inpatient medical care vis-à-vis clinical severity.
Cupurdija V; Lazic Z; Petrovic M; Mojsilovic S; Cekerevac I; Rancic N; Jakovljevic M
J Bras Pneumol; 2015; 41(1):48-57. PubMed ID: 25750674
[TBL] [Abstract][Full Text] [Related]
15. Private costs of patients hospitalized with community-acquired pneumonia.
Jacobs P; Marrie TJ; Calder P
Can Respir J; 2005; 12(4):205-8. PubMed ID: 16003457
[TBL] [Abstract][Full Text] [Related]
16. Burden of hospitalized childhood community-acquired pneumonia: A retrospective cross-sectional study in Vietnam, Malaysia, Indonesia and the Republic of Korea.
Tan KK; Dang DA; Kim KH; Kartasasmita C; Kim HM; Zhang XH; Shafi F; Yu TW; Ledesma E; Meyer N
Hum Vaccin Immunother; 2018 Jan; 14(1):95-105. PubMed ID: 29125809
[TBL] [Abstract][Full Text] [Related]
17. Hospitalization costs of adult community-acquired pneumonia in England.
Campling J; Wright HF; Hall GC; Mugwagwa T; Vyse A; Mendes D; Slack MPE; Ellsbury GF
J Med Econ; 2022; 25(1):912-918. PubMed ID: 35726515
[TBL] [Abstract][Full Text] [Related]
18. Clinical and economic burden of community-acquired pneumonia in the Medicare fee-for-service population.
Yu H; Rubin J; Dunning S; Li S; Sato R
J Am Geriatr Soc; 2012 Nov; 60(11):2137-43. PubMed ID: 23110409
[TBL] [Abstract][Full Text] [Related]
19. The epidemiology and healthcare costs of community-acquired pneumonia in Ontario, Canada: a population-based cohort study.
O'Reilly R; Lu H; Kwong JC; McGeer A; To T; Sander B
J Med Econ; 2023; 26(1):293-302. PubMed ID: 36756847
[TBL] [Abstract][Full Text] [Related]
20. Hospitalized low-risk community-acquired pneumonia: outcome and potential for cost-savings.
Hoe LK; Keang LT
Respirology; 1999 Sep; 4(3):307-9. PubMed ID: 10489681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
